Skip to main content
Post Operative Pain, AcutePainDental and oral healthDrugPhase 1, Phase 2

What this study is

Possible participants will be scheduled to have 2 gum flap surgeries done on 2 similar surgical sites in the mouth. The study looks at two different ways of giving dexamethasone, a medication used to reduce inflammation. The researchers want to learn if taking dexamethasone by mouth works similarly to receiving dexamethasone through the participant's vein (intravenous, or IV) in reducing short-term pain, swelling, and pain medication after periodontal (gum) flap surgery.

The periodontal evaluation, treatment planning, IV sedation, gum surgery, sutures, and usual postoperative care are part of standard care and would be done even if a participant does not join the study. After joining the study, participants will be randomly assigned to the order in which they receive dexamethasone. At one surgery, participants will receive IV dexamethasone plus oral placebo (an inactive substance that looks the same but does not contain dexamethasone). At the next surgery, participants will receive oral dexamethasone plus IV placebo. As part of the study, participants will be asked to record your pain, swelling and any other medication use.

What's being tested

  • Dexamethasone IV injection

    Intervention · DRUG

    Dexamethasone 8mg/2ml administered intravenously at gum flap surgery

  • Dexamethasone Capsule

    Intervention · DRUG

    Dexamethasone 8 mg capsule will be administered at gum flap surgery

  • Placebo IV administration

    Intervention · OTHER

    Placebo used for dexamethasone IV injection at gum flap surgery

  • Placebo capsule

    Intervention · OTHER

    Placebo capsule is administered at gum flap surgery

Study details

Official title
The Effect of Dexamethasone on Short Term Patient Response: Intravenous vs. Oral Administration
Sponsor
The University of Texas Health Science Center at San Antonio
Conditions
Post Operative Pain, Acute · Periodontitis
Enrolling
40 people
Starts
2026-10
Est. completion
2029-03
Design
Quadruple-blind, randomized, crossover, Phase 1, Phase 2
Record
View on ClinicalTrials.gov ↗